Latest Insider Transactions at Sellas Life Sciences Group, Inc. (SLS)
This section provides a real-time view of insider transactions for Sellas Life Sciences Group, Inc. (SLS). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of SELLAS Life Sciences Group, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of SELLAS Life Sciences Group, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 02
2021
|
John Thomas Burns CFO |
SELL
Open market or private sale
|
Direct |
231
-1.29%
|
$1,386
$6.27 P/Share
|
|
Dec 02
2021
|
Barbara A Wood EVP, Gen. Counsel, Corp. Sec. |
SELL
Open market or private sale
|
Direct |
847
-1.98%
|
$5,082
$6.25 P/Share
|
|
Dec 02
2021
|
Angelos M. Stergiou President and CEO |
SELL
Open market or private sale
|
Direct |
2,120
-1.72%
|
$12,720
$6.25 P/Share
|
|
Mar 04
2021
|
Angelos M. Stergiou President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
19,750
+16.73%
|
-
|
|
Mar 04
2021
|
John Thomas Burns CFO |
BUY
Grant, award, or other acquisition
|
Direct |
2,875
+18.25%
|
-
|
|
Mar 04
2021
|
Barbara A Wood EVP, Gen. Counsel, Corp. Sec. |
BUY
Grant, award, or other acquisition
|
Direct |
7,875
+19.33%
|
-
|